Chronic villitis in untreated neonatal alloimmune thrombocytopenia: An etiology for severe early intrauterine growth restriction and the effect of intravenous immunoglobulin therapy-Reference-Cited by-同舟云学术

Chronic villitis in untreated neonatal alloimmune thrombocytopenia: An etiology for severe early intrauterine growth restriction and the effect of intravenous immunoglobulin therapy

Published:2005-09 Issue:3 Volume:193 Page:1100-1104
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Althaus Janyne,Weir Edward G.,Askin Fred,Kickler Thomas S.,Blakemore Karin

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference24 articles.

1. Neonatal alloimmune thrombocytopenia: antenatal management;Silver;Am J Obstet Gynecol,2000

2. Fetal and neonatal alloimmune thrombocytopenia in pregnancies involving in vitro fertilization: a report of four cases;Curtis;Am J Obstet Gynecol,2005

3. Neonatal alloimmune thrombocytopenia;Kickler;Clin Lab Med,1992

4. Fetal and neonatal thrombocytopenia;Udom-Rice;Blood Rev,1995

5. Antenatal interventions for fetomaternal alloimmune thrombocytopenia;Rayment;Cochrane Database Syst Rev,2005

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does anti‐HPA‐1a affect birthweight in fetal and neonatal alloimmune thrombocytopenia?;Pediatric Blood & Cancer;2024-01-11

2. Maternal Factors and Placental Pathologies Associated with a Diagnosis of Chronic Villitis;American Journal of Perinatology;2023-12-06

3. Natural history of human platelet antigen 1a-alloimmunised pregnancies: a prospective observational cohort study;The Lancet Haematology;2023-12

4. Recurrence risk of villitis of unknown etiology: Analysis of a large retrospective cohort study, systematic review and meta-analysis;Placenta;2022-03

5. The Potential Benefit of Hydroxychloroquine in Chronic Placental Inflammation of Unknown Etiology Associated with Adverse Pregnancy Outcomes;Healthcare;2022-01-17